Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy as first-line treatment for extensive-stage small cell lung cancer: a meta-analysis based on mixed-effect models.
Frontiers in medicine（2023）
摘要
PROSPERO, identifier: CRD42022348496.
更多查看译文
关键词
immune checkpoint inhibitors,small cell lung cancer,lung cancer,chemotherapy,first-line,extensive-stage,meta-analysis,mixed-effect
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要